Peripheral nerves have the capacity
to regenerate due to the presence
of neuroprotective glia of the peripheral nervous system, Schwann
cells. Upon peripheral nerve injury, Schwann cells create a permissive
microenvironment for neuronal regrowth by taking up cytotoxic glutamate
and secreting neurotrophic signaling molecules. Impaired peripheral
nerve repair is often caused by a defective Schwann cell response
after injury, and there is a critical need to develop new strategies
to enhance nerve regeneration, especially in organisms with restricted
regenerative potential, such as humans. One approach is to explore
mechanisms in lower organisms, in which nerve repair is much more
efficient. A recent study demonstrated that the antiparasitic drug,
ivermectin, caused hyperinnervation of primordial eye tissue in Xenopus laevis tadpoles. Our study aimed to examine
the role of ivermectin in mammalian nerve repair. We performed in
vitro assays utilizing human induced neural stem cells (hiNSCs) in
co-culture with human dermal fibroblasts (hDFs) and found that ivermectin-treated
hDFs promote hiNSC proliferation and migration. We also characterized
the effects of ivermectin on hDFs and found that ivermectin causes
hDFs to uptake extracellular glutamate, secrete glial cell-derived
neurotrophic factor, develop an elongated bipolar morphology, and
express glial fibrillary acidic protein. Finally, in a corresponding
in vivo model, we found that localized ivermectin treatment in a dermal
wound site induced the upregulation of both glial and neuronal markers
upon healing. Taken together, we demonstrate that ivermectin promotes
peripheral nerve regeneration by inducing fibroblasts to adopt a glia-like
phenotype.